Clinical Trial Closeup
Coding & Medicare
Imaging & Diagnostics
Surgical Pearl Video
Surgical Techniques & Tools
CST changes and VA in nAMD: A review of the evidence
Post-hoc analyses and real-world studies demonstrate the link between central subfoveal thickness fluctuations and visual acuity in neovascular age-related macular degeneration.
Metformin’s potential impact on AMD prevention
Multiple observational studies have shown the potential of the antidiabetic drug in the management of age-related macular degeneration.
Reframing the discussion around geographic atrophy
Understanding the natural disease progression will help us talk to our patients about new and emerging treatments.
Understanding the risk of GA in nAMD
A look at research that sheds new light into the progression of geographic atrophy in neovascular age-related macular degeneration.
Update on mitochondrial stabilizers
Also from the Angiogenesis, Exudation, and Degeneration meeting, emerging treatments for nAMD and MacTel2, and a marker for anti-VEGF success in ROP.
Axitinib implant shows early potential
Interim results from Phase I trial of OTX-TKI, a bioresorbable hydrogel platform using a tyrosine kinase inhibitor.
AAO Report: New insights into ILM tears, trial readouts and more
Five abstracts on gene therapy and role of central subfield thickness in diabetic macular edema, vitreous hemorrhage and retinopathy of prematurity.
Treat and extend: An international view
Three experts from Canada, Switzerland and Israel provide insights into the nuances of adherence, treatment intervals and emerging therapies.
A closer look at emerging drug-delivery platforms
An update on Port Delivery System with ranibizumab, a large-molecule anti-VEGF candidate and subretinal gene therapy to treat neovascular AMD.
Retinal implant platforms moving from uveitis to AMD
Treatments show potential for various posterior-segment diseases based on their success treating noninfectious uveitis.
Table of Contents
Connect With Us
Continuing Medical Education
Breaking New Ground: Reducing Treatment Burden in nAMD
View More CME
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
View More Publications
Review Of Ophthalmology
Table of Contents
LRIs: Still a Valuable Asset for Astigmatism
Glaucoma: Detecting OCT Artifacts
Managing Refractive Surgery Complications
Do Not Sell My Personal Information
Your Privacy Choices
Copyright © 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.